Iter-4360dd15-0070-transcript
第 70 轮执行轨迹
→ call search_memory({"limit":8,"query":"4360dd15 33977284 29408453 abstract endpoint aging criteria audit table"}) → call list_recent({"n":8})
→ call list_by_tag({"limit":10,"tag":"4360dd15"})
【tool:search_memory】
{"ok": true, "results": [{"title": "Iter-4360dd15-0010-transcript", "tags": "iteration transcript", "modified": "20260424175830000", "preview": "!! 第 10 轮执行轨迹
→ cal"}, {"title": "Iter-4360dd15-0060-transcript", "tags": "iteration transcript", "modified": "20260424200117000", "preview": "!! 第 60 轮执行轨迹 →"}, {"title": "Iter-4360dd15-0037-transcript", "tags": "iteration transcript", "modified": "20260424191347000", "preview": "!! 第 37 轮执行轨迹 【tool:list_recent】
{"ok": true, "items": [{"title": "Error-20260425-041443", "modified": "20260424201443000", "tags": "error iteration"}, {"title": "Iter-4360dd15-0068-reflection", "modified": "20260424201421000", "tags": "iteration reflection"}, {"title": "NEXT_FOCUS", "modified": "20260424201421000", "tags": "pinned focus"}, {"title": "先用现成抓取验证，再封装工具", "modified": "20260424201421000", "tags": "lesson tooling verification abstract-extraction"}, {"title": "Iter-4360dd15-0068-transcript", "modified": "20260424201415000", "tags": "iteration transcript"}, {"title": "Iter-4360dd15-0068-abstract-endpoint-extraction", "modified": "20260424201407000", "tags": "4360dd15 knowledge fact method"}, {"title": "Iter-4360dd15-0067-reflection", "modified": "20260424201155000", "tags": "iteration reflection"}, {"title": "优先用可访问全文源替代出版社页", "modified": "20260424201155000", "tags": "lesson pubmed-verification europe-pmc abstract-extraction"}]}
【tool:list_by_tag】
{"ok": true, "items": [{"title": "Iter-4360dd15-0068-abstract-endpoint-extraction", "modified": "20260424201407000"}, {"title": "Iter-4360dd15-0067-abstract-endpoints-aging-criteria", "modified": "20260424201141000"}, {"title": "Iter-4360dd15-0066-TierA-abstracts-and-endpoints-for-aging-criteria", "modified": "20260424200925000"}, {"title": "Iter-4360dd15-0065-minimal-relevance-decision-rules-for-retained-mtor-trials", "modified": "20260424200748000"}, {"title": "Iter-4360dd15-0064-relevance-tiering-10-pmids", "modified": "20260424200602000"}, {"title": "Iter-4360dd15-0063-10-pmid-audit-table", "modified": "20260424200432000"}, {"title": "Iter-4360dd15-0062-pubmed-title-verification-10-pmids", "modified": "20260424200328000"}, {"title": "Iter-4360dd15-0061-candidate-audit-10-remaining-pmids", "modified": "20260424200221000"}, {"title": "PMID 38310895 is a review, not a primary trial", "modified": "20260424200109000"}, {"title": "PMID 35040506 longitudinal analysis is embedded in primary trial", "modified": "20260424195939000"}]}
→ call read_note({"title":"NEXT_FOCUS"})
→ call read_note({"title":"Iter-4360dd15-0068-abstract-endpoint-extraction"})
→ call read_note({"title":"Iter-4360dd15-0067-abstract-endpoints-aging-criteria"})
【tool:read_note】
{"ok": true, "title": "NEXT_FOCUS", "tags": "pinned focus", "text": "!! 下轮焦点（来自 mission 4360dd15 · Iter-0068）\n\n把这两篇试验的摘要中“主要终点/年龄判据”整理成可复用的标准化审计表，并立刻写入长期记忆。"}
【tool:read_note】
{"ok": true, "title": "Iter-4360dd15-0068-abstract-endpoint-extraction", "tags": "4360dd15 knowledge fact method", "text": "!! 第 68 轮：从 PMC 可访问全文抽取两篇试验的 primary outcome 与直接衰老判据\n\n本轮子任务：只做一件事——把 PMID 33977284 与 PMID 29408453 的 primary outcome 和最直接的衰老相关判据从可访问全文中定位出来，作为后续审计的可复用证据。\n\n!! PMID 33977284\n'''题名'''：Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials\n\n'''可验证的 primary outcome'''\n- phase 2b primary outcome = 16 周冬季流感/感冒季期间 laboratory-confirmed RTIs 的发生率。\n- phase 3 primary outcome = clinically symptomatic respiratory illness 的发生率（无论是否实验室确认）。\n\n'''最直接的衰老相关判据'''\n- 纳入标准：''adults aged at least 65 years''。\n- 生物学 aging proxy：IFN-induced antiviral gene expression 的上调。\n- 结果层 aging proxy：RTI 易感性 / 感染负担是否下降。\n- 该试验没有把寿命或疾病自由生存作为终点，因此只能归为 immune-aging / infection-proxy evidence，不能夸大为 longevity endpoint。\n\n'''可访问来源'''\n- PMC：https://pmc.ncbi.nlm.nih.gov/articles/PMC8102040/\n- PMID：33977284\n\n!! PMID 29408453\n'''题名'''：A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects\n\n'''可验证的 primary endpoint / 研究主线'''\n- 摘要明确指向 feasibility and safety。\n- 监测的主要结果域包括：CBC/CMP/HbA1c/OGTT；认知（EXIT25、SLUMS、TAPS）；体能（handgrip strength、40-foot timed walks）；免疫衰老（pro-inflammatory cytokines、blood cell subsets）。\n\n'''最直接的衰老相关判据'''\n- 纳入对象：''generally healthy older adults (
【tool:read_note】
{"ok": true, "title": "Iter-4360dd15-0067-abstract-endpoints-aging-criteria", "tags": "4360dd15 knowledge fact method stratification", "text": "!! 第 67 轮：从两篇 Tier A 试验抽取主要终点与最直接的衰老判据\n\n本轮目标：只从 PMID 33977284 与 PMID 29408453 的可访问摘要中，提取“主要终点”与“最直接的衰老相关判据”，作为后续审计/分层的可复用规则。\n\n!! PMID 33977284\n'''题名'''：Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials.\n\n'''可访问摘要中的主要终点'''\n- phase 2b：16 周冬季感冒/流感季期间的 laboratory-confirmed RTIs 发生率；摘要中指出在第二个预设分析里，RTB101 10 mg 每日一次降低了至少一次 laboratory-confirmed RTI 的比例。\n- phase 3：clinically symptomatic respiratory illness 的发生率（不要求实验室确认）。\n\n'''最直接的衰老相关判据'''\n- 研究对象：至少 65 岁的 older adults。\n- 生物学判据：IFN-induced antiviral gene expression 上调。\n- 结果层面的 aging proxy：RTI 易感性/感染负担是否下降。\n- 该文并未把寿命或功能衰退作为终点，而是把“老年免疫衰老”映射到抗病毒反应与呼吸道感染结局。\n\n'''Europe PMC / core 元数据证据'''\n- PMID: 33977284\n- PMCID: PMC8102040\n- DOI: 10.1016/S2666-7568(21)00062-3\n- abstractText 明确给出 phase 2b 与 phase 3 的 primary outcome。\n\n!! PMID 29408453\n'''题名'''：A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects.\n\n'''可访问摘要中的主要终点/监测重点'''\n- 安全性/耐受性：feasibility and safety。\n- 代谢安全性：CBC、CMP、HbA1c、OGTT。\n- 认知：EXIT25、SLUMS、TAPS。\n- 体能：handgrip strength、40-foot timed walks。\n- 免疫衰老：serum pro-inflammatory cytokines、blood cell subsets。\n\n'''最直接的衰老相关判据'''\n- 研究对象：70–95 岁 healthy older
→ call web_fetch({"max_chars":5000,"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8102040/"})
→ call web_fetch({"max_chars":5000,"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5869166/"})
【tool:web_fetch】
{"ok": true, "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8102040/", "status": 200, "content_type": "text/html; charset=utf-8", "text": "Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials - PMC Skip to main content An official website of the United States government Here's how you know Here's how you know Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock ( Lock Locked padlock icon ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites. Search Log in Dashboard Publications Account settings Log out Search… Search NCBI Primary site navigation Search Logged in as: Dashboard Publications Account settings Log in Search PMC Full-Text Archive Search in PMC Journal List User Guide PERMALINK Copy As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: PMC Disclaimer | PMC Copyright Notice Lancet Healthy Longev . 2021 May 6;2(5):e250–e262. doi: 10.1016/S2666-7568(21)00062-3 Search in PMC Search in PubMed View in NLM Catalog Add to search Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials Joan B Man
【tool:web_fetch】
{"ok": true, "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5869166/", "status": 200, "content_type": "text/html; charset=utf-8", "text": "A Randomized Control Trial to Establish the Feasibility and Safety of Rapamycin Treatment in an Older Human Cohort: Immunological, Physical Performance, and Cognitive Effects - PMC Skip to main content An official website of the United States government Here's how you know Here's how you know Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock ( Lock Locked padlock icon ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites. Search Log in Dashboard Publications Account settings Log out Search… Search NCBI Primary site navigation Search Logged in as: Dashboard Publications Account settings Log in Search PMC Full-Text Archive Search in PMC Journal List User Guide PERMALINK Copy As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: PMC Disclaimer | PMC Copyright Notice Exp Gerontol . Author manuscript; available in PMC: 2019 May 1. Published in final edited form as: Exp Gerontol. 2018 Feb 3;105:53–69. doi: 10.1016/j.exger.2017.12.026 Search in PMC Search in PubMed View in NLM Catalog Add to search A Randomized Control Tria
→ call write_note({"tags":["4360dd15","knowledge","fact","method"],"text":"!! 第 70 轮：两篇 Tier A 试验的标准化审计表\n\n本轮子任务：把 PMID 33977284 与 PMID 29408453 的摘要/可访问全文中“主要终点 / 年龄判据”压缩成一个可复用的审计表，便于后续批量筛查与分层。\n\n| PMID | 研究题名 | 研究类型 | 年龄判据 / 入组人群 | 主要终点（primary outcome / main endpoint） | 最直接的衰老相关判据 | 审计分类 |\n|---|---|---|---|---|---|---|\n| 33977284 | Targeting the biology of ageing with mTOR inhibitors to improve immune functio)
→ call write_note({"tags":["4360dd15","pinned focus","next"],"text":"!! 下轮焦点（来自 mission 4360dd15 · Iter-0069）\n\n把这张审计表推广成“可批量应用的抽取模板”：明确每类试验在摘要中应抓取的字段、允许的同义表达、以及把它们自动判成 longevity / proxy / feasibility 的最小规则集。","title":"NEXT_FOCUS"})
【tool:write_note】
{"ok": true, "path": "C:\\Users\\yh599\\Documents\\GitHub\\LLM-yh\\Sisyphus\\wiki\\tiddlers\\Iter-4360dd15-0069-standardized-audit-table-two-trials.tid", "title": "Iter-4360dd15-0069-standardized-audit-table-two-trials"}
【tool:write_note】
{"ok": true, "path": "C:\\Users\\yh599\\Documents\\GitHub\\LLM-yh\\Sisyphus\\wiki\\tiddlers\\NEXT_FOCUS.tid", "title": "NEXT_FOCUS"}
【assistant】
本轮已完成：把 PMID 33977284 与 PMID 29408453 整理成了统一的标准化审计表，并写入长期记忆。
关键压缩结论：
- 33977284：年龄判据是 adults aged at least 65 years；主要终点是 RTI/clinically symptomatic respiratory illness；应归为 immune-aging / infection-proxy evidence
- 29408453：年龄判据是 healthy older adults aged 70–95 years；主要终点主线是 feasibility and safety；应归为 geroprotector feasibility/safety pilot
已写入的长期记忆：
- Iter-4360dd15-0069-standardized-audit-table-two-trials
- 更新了 NEXT_FOCUS
< NEXT_FOCUS >把这张审计表推广成“可批量应用的抽取模板”：明确每类试验在摘要中应抓取的字段、允许的同义表达、以及把它们自动判成 longevity / proxy / feasibility 的最小规则集。</NEXT_FOCUS>
```